Metraipolis › archive › dc_3cc40156a783

Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis — Europe PMC PMID:42123166

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123166
DOI
10.3390/jcm15093433
License (as archived)
solo-consultazione
Archived
2026-11-02T21:05:00.425Z
SHA-256 of the archived text
5569abc94e8e415f774a7877bc97108b6778c9ba7fc635f56e17ec7cbdaba396
Stable URL of this page
https://metraipolis.com/documento/dc_3cc40156a783

How to cite

Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis — Europe PMC PMID:42123166 — Europe PMC (en), https://europepmc.org/article/MED/42123166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cc40156a783 (Metraipolis archive dc_3cc40156a783, sha256 5569abc94e8e415f774a7877bc97108b6778c9ba7fc635f56e17ec7cbdaba396)
BibTeX
@misc{dc3cc40156a783,
  title = {Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis — Europe PMC PMID:42123166},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123166},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cc40156a783; sha256 5569abc94e8e415f774a7877bc97108b6778c9ba7fc635f56e17ec7cbdaba396},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123166. Agents can read the archived copy with the MCP tool read_document.